Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Humira, Rituxan Top List of U.S. Drugs with Biggest Price Increases

Caroline Humer  |  

Humira’s net price increase over 2017 and 2018 added $1.8 billion in spending, while Rituxan added $806 million, the report said.

Reporting by Caroline Humer; Editing by Richard Chang and Bill Berkrot

ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Institute for Clinical and Economic Review. News release: ICER identifies costliest U.S. drug price hikes that are not supported by new clinical evidence. 2019 Oct 8.
  2. Institute for Clinical and Economic Review. Unsupported price increase report: 2019 assessment. 2019 Oct 8.

Related Articles

    Major Drugmakers Push Back in U.S. Price Debate

    SAN FRANCISCO (Reuters)—With a backlash brewing over the price of medicines in the U.S., drugmakers are pushing back with a new message: Most people don’t pay retail. Top executives from Eli Lilly and Co, Merck & Co and Biogen Inc. said in interviews with Reuters this week that the media focus on retail, or “list…

    Opinion: Help Bring Drug Prices Down

    I read with interest the articles in the June issue of The Rheumatologist pertaining to high drug costs. Simon Helfgott rheuminated on it, and Susan Bernstein, a medical journalist, wrote a two-page article titled “Concerns About Cost.” Both articles were thoughtful summaries of a complex issue, putting large question marks over both initial prices and…